skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: First comprehensive identification of cardiac proteins with putative increased O-GlcNAc levels during pressure overload hypertrophy

Journal Article · · PLoS ONE
 [1];  [2]; ORCiD logo [2];  [3]; ORCiD logo [2];  [2]; ORCiD logo [3]
  1. Seattle Children’s Research Institute, Seattle, WA (United States)
  2. Pacific Northwest National Lab. (PNNL), Richland, WA (United States). Environmental Molecular Sciences Division
  3. Seattle Children’s Research Institute, Seattle, WA (United States); Univ. of Washington, Seattle, WA (United States)

Protein posttranslational modifications (PTMs) by O-GlcNAc globally rise during pressure-overload hypertrophy (POH). However, a major knowledge gap exists on the specific proteins undergoing changes in O-GlcNAc levels during POH primarily because this PTM is low abundance and easily lost during standard mass spectrometry (MS) conditions used for protein identification. Methodologies have emerged to enrich samples for O-GlcNAcylated proteins prior to MS analysis. Accordingly, our goal was to identify the specific proteins undergoing changes in O-GlcNAc levels during POH. We used C57/Bl6 mice subjected to Sham or transverse aortic constriction (TAC) to create POH. From the hearts, we labelled the O-GlcNAc moiety with tetramethylrhodamine azide (TAMRA) before sample enrichment by TAMRA immunoprecipitation (IP). We used LC-MS/MS to identify and quantify the captured putative O-GlcNAcylated proteins. We identified a total of 700 putative O-GlcNAcylated proteins in Sham and POH. Two hundred thirty-three of these proteins had significantly increased enrichment in POH over Sham suggesting higher O-GlcNAc levels whereas no proteins were significantly decreased by POH. We examined two MS identified metabolic enzymes, CPT1B and the PDH complex, to validate by immunoprecipitation. We corroborated increased O-GlcNAc levels during POH for CPT1B and the PDH complex. Enzyme activity assays suggests higher O-GlcNAcylation increases CPT1 activity and decreases PDH activity during POH. In summary, we generated the first comprehensive list of proteins with putative changes in O-GlcNAc levels during POH. Our results demonstrate the large number of potential proteins and cellular processes affected by O-GlcNAc and serve as a guide for testing specific O-GlcNAc-regulated mechanisms during POH.

Research Organization:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC05-76RL01830
OSTI ID:
1900156
Report Number(s):
PNNL-SA-170854
Journal Information:
PLoS ONE, Vol. 17, Issue 10; ISSN 1932-6203
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
English

References (34)

C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle journal February 2013
The intra-mitochondrial O-GlcNAcylation system rapidly modulates OXPHOS function and ROS release in the heart journal April 2022
O-GlcNAc profiling: from proteins to proteomes journal March 2014
Targeting O-GlcNAcylation to develop novel therapeutics journal June 2021
Cardiomyocyte Ogt is essential for postnatal viability journal January 2014
The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine journal February 2010
O-GlcNAcylation, enemy or ally during cardiac hypertrophy development? journal December 2016
Protein O-linked β-N-acetylglucosamine: A novel effector of cardiomyocyte metabolism and function journal March 2012
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure journal January 2012
Protein O-GlcNAcylation in Cardiac Pathologies: Past, Present, Future journal January 2019
First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in ex vivo mouse heart journal February 2020
PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis journal February 2017
Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy journal March 2017
Regulation of a Cytosolic and Nuclear O -GlcNAc Transferase : ROLE OF THE TETRATRICOPEPTIDE REPEATS journal November 1999
Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload Hypertrophy journal August 2012
Gender differences in molecular remodeling in pressure overload hypertrophy journal July 1999
Cardiac Energy Metabolism in Heart Failure journal May 2021
The Perseus computational platform for comprehensive analysis of (prote)omics data journal June 2016
Protein O ‐GlcNAcylation levels are regulated independently of dietary intake in a tissue and time‐specific manner during rat postnatal development journal October 2020
Protein O-GlcNAcylation: emerging mechanisms and functions journal May 2017
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation journal January 2018
Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. journal March 1984
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists journal November 2008
Re-balancing cellular energy substrate metabolism to mend the failing heart journal May 2020
New approach for understanding genome variations in KEGG journal October 2018
O‐GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O‐GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload journal June 2019
Female sex and estrogen receptor-β attenuate cardiac remodeling and apoptosis in pressure overload journal June 2010
Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling journal April 2020
Protein O -GlcNAcylation and Cardiovascular (Patho)physiology journal October 2014
Metabolic Remodeling Promotes Cardiac Hypertrophy by Directing Glucose to Aspartate Biosynthesis journal January 2020
The human O-GlcNAcome database and meta-analysis journal January 2021
c-Myc Alters Substrate Utilization and O-GlcNAc Protein Posttranslational Modifications without Altering Cardiac Function during Early Aortic Constriction journal August 2015
A rapid spectrophotometric assay for carnitine palmitoyltransferase journal December 1972
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources journal December 2008

Similar Records

C-Myc Induced Compensated Cardiac Hypertrophy Increases Free Fatty Acid Utilization for the Citric Acid Cycle
Journal Article · Fri Feb 01 00:00:00 EST 2013 · Journal of Molecular and Cellular Cardiology, 55:156-164 · OSTI ID:1900156

C-Myc regulates substrate oxidation patterns during early pressure-overload hypertrophy
Journal Article · Tue Nov 26 00:00:00 EST 2013 · Circulation · OSTI ID:1900156

Tandem Mass Spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets
Journal Article · Tue May 08 00:00:00 EDT 2012 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1900156